Emmessar Biotech & Nutrition share news, announcements and annual reports
BSE: 524768Chemicals & PetrochemicalsSmall Cap
Emmessar Biotech & Nutrition Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1995
Last close ₹22.74up ₹1.08 (4.99%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹21.66.
28 Oct: open ₹23.44, high ₹23.44, low ₹21.14
52-week range of traded prices to 28 Oct 2026
₹18.42Low, 24 Mar 2026₹33.38High, 20 Nov 2025
- Next results date: the board meets on 31 Oct 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹11 Cr4,463rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 28.68
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.40
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 320
Emmessar Biotech & Nutrition disputes and clarifications
25 filed, newest first.
Nov 2024
7 Nov · Legal
6 Nov · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on November 6, 2024 with reference to significant movement in price, in order to ensure that investors have latest ....
Jul 2024
16 Jul · Legal
15 Jul · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on July 15, 2024 with reference to significant movement in price, in order to ensure that investors have latest ....
Nov 2023
Nov 2022
24 Nov · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on November 24, 2022, with reference to Movement in Price. The reply is awaited.
Apr 2022
12 Apr · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on April 12, 2022 with reference to significant movement in price, in order to ensure that investors have latest ....
Jan 2022
13 Jan · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on January 13, 2022 with reference to significant movement in price, in order to ensure that investors have latest ....
Jul 2021
14 Jul · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on July 14, 2021 with reference to significant movement in price, in order to ensure that investors have latest ....
Jun 2021
1 Jun · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on June 1, 2021 with reference to significant movement in price, in order to ensure that investors have latest ....
Apr 2021
28 Apr · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on April 28, 2021 with reference to significant movement in price, in order to ensure that investors have latest ....
Nov 2020
25 Nov · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on November 25, 2020 with reference to significant movement in price, in order to ensure that investors have ....
Jul 2019
15 Jul · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on July 15, 2019 with reference to significant movement in price, in order to ensure that investors have latest ....
Feb 2019
21 Feb · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on February 21, 2019 with reference to significant movement in price, in order to ensure that investors have ....
Oct 2017
30 Oct · Legal
30 Oct · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on October 30, 2017 , with reference to increase in Price. The reply is awaited.